Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

Low-dose naltrexone helps reduce symptoms and slow down lichen planopilaris without side effects.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

Alopecia treatments improve life quality but side effects can lessen this benefit; better use of quality of life measures is needed.

Antihelminthic drugs treat worm infections but face challenges like low treatment coverage and potential drug resistance, with various side effects reported for different drugs.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Trigonelline nanocrystal cream effectively promotes hair growth and may reduce side effects.

Connarus semidecandrus Jack extract promotes hair growth and thickness, reduces prostate cancer cell growth, and could potentially be used as a treatment for hair loss.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

Laser-assisted drug delivery has shown improved treatment outcomes for skin conditions and has potential to reduce side effects and treatment time.

Tacrolimus is an effective treatment for several skin conditions with fewer side effects than cyclosporine.

New skin disease treatments using TDDS are improving but face challenges like side effects and high costs.

The new topical botanical formulation significantly regrew hair in all five patients without side effects.

Rosemary oil may effectively treat hair loss with fewer side effects, but more research is needed.

Taking 5 mg/day finasteride can cause side effects in women with hair loss, but these are usually mild and fade over time, making the treatment beneficial in the long run.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Low-dose flutamide improved hirsutism and satisfaction in women but had common side effects, causing some to stop treatment.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Finasteride caused long-term sexual and non-sexual side effects in young men with hair loss.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.